Form 4: Perrigo Executive Receives Restricted Stock Units

Perrigo Company plc EVP Matthew Winterman was granted 22,388 restricted stock units as part of an equity compensation plan.

Summary

• Matthew John Winterman, EVP of Supply, Ops, and Strategy at Perrigo Company plc, was granted 22,388 restricted stock units (RSUs).
• Each RSU represents a contingent right to receive one ordinary share of Perrigo Company plc.
• The RSUs are scheduled to vest in three equal annual installments beginning on May 13, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding executive compensation, which carries a neutral sentiment.

Positives

• The grant of equity aligns the executive's interests with those of long-term shareholders.

Negatives

• None identified.

Risks

• The value of the granted equity is subject to market fluctuations in Perrigo's share price.

Future Outlook

The RSUs will vest in three equal annual installments starting May 13, 2027, contingent upon continued service.

Industry Context

StockSavvy.ai notes that equity grants to senior executives are standard corporate governance practices designed to incentivize long-term performance and retention within the pharmaceutical and consumer goods sectors.

Comparison to Industry Standards

• The use of multi-year vesting schedules for RSU grants is consistent with standard executive compensation practices among large-cap pharmaceutical companies.
• The structure of the grant aligns with typical equity incentive plans used by peers such as Viatris or Haleon.

Stakeholder Impact

• Shareholders may view the equity grant as a standard alignment of executive incentives with company performance.

Next Steps

• Vesting of the first tranche of RSUs on May 13, 2027.

Key Dates

Keywords

Perrigo, PRGO, Form 4, Insider Trading, Equity Compensation, Restricted Stock Units